Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$185.1 - $233.13 $15.2 Million - $19.1 Million
82,000 Added 69.49%
200,000 $46.3 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $27.5 Million - $31.3 Million
118,000 New
118,000 $29.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $179B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track Jeffrey Ubben's Portfolio

Track Jeffrey Ubben Portfolio

Follow Jeffrey Ubben (Value Act Holdings, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Act Holdings, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Value Act Holdings, L.P. and Jeffrey Ubben with notifications on news.